/
/
Ein orthotopisches Endometriumkrebs-Modell mit retroperitonealer Lymphadenopathie made From In Vivo Propagated and Cultured VX2 Cells
É necessária uma assinatura da JoVE para visualizar este conteúdo. Faça login ou comece sua avaliação gratuita.
1Institute of Medical Science,University of Toronto, 2Department of Obstetrics and Gynecology,University of Toronto, 3Guided Therapeutics Laboratory, TECHNA Institute,University Health Network, 4Department of Pathology, Princess Margaret Cancer Center,University Health Network, 5Department of Medical Biophysics,University of Toronto, 6Princess Margaret Cancer Center,University Health Network, 7Techna Institute,University Health Network, 8Department of Surgery,University of Toronto, 9Department of Otolaryngology, Head and Neck Surgery,University of Toronto, 10Division of Gynecologic Oncology, University of Toronto /Princess Margaret Cancer Center,University Health Network, 11Princess Margaret Cancer Center,University Health Network
Capítulos
- 00:04Título
- 00:59In Vitro-Propagated VX2 Cell Suspension Preparation
- 02:35In Vivo-Propagated VX2 Cell Suspension Preparation
- 03:27Surgical Field Preparation
- 04:17Laparotomy and Uterine Horn Identification
- 05:31Myometrial VX2 Cell Inoculation
- 06:21Surgical Incision Closure and Post-Operative Care
- 08:03Results: VX2 Tumor Establishment and Characterization
- 09:09Conclusion
Dieses Protokoll stellt eine standardisierte Methode zum Wachstum von VX2-Zellen in Kultur dar und zur Erstellung eines orthotopischen VX2-Modells von Endometriumkrebs mit retroperitonealen Lymphknotenmetastasen bei Kaninchen. Orthotopische Endometriumkrebsmodelle sind wichtig für die präklinische Untersuchung neuartiger bildgebender Modalitäten für die Diagnose von Lymphknotenmetastasen.
